Literature DB >> 14663289

Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases.

Jean Henrion1, Michael Schapira, Raymond Luwaert, Lucien Colin, André Delannoy, Françis R Heller.   

Abstract

The centrilobular liver cell necrosis observed in hypoxic hepatitis is generally attributed to failure of hepatic blood perfusion. Accordingly, this injury of the liver is commonly recognized under the terms "shock liver" or "ischemic hepatitis." During a 10-year period, 142 episodes of hypoxic hepatitis were consecutively identified in the intensive care unit of a general hospital, and the clinical, biological, and hemodynamic parameters were prospectively collected on individual files. We conducted the current study to assess retrospectively the role of the hemodynamic mechanisms of tissue hypoxia: ischemia, passive venous congestion, and hypoxemia. Among the 142 episodes of hypoxic hepatitis, 138 were separated in 4 main groups based on clinical features: decompensated congestive heart failure (80 cases), acute cardiac failure (20 cases), exacerbated chronic respiratory failure (19 cases), and toxic/septic shock (19 cases). An elementary hemodynamic evaluation, including blood pressure, central venous pressure, and arterial blood gas analysis, was carried out in every episode and a more complete hemodynamic assessment through pulmonary artery catheterization was performed in 61 episodes. The hemodynamic mechanisms responsible for hypoxic hepatitis were different in the 4 groups. In congestive heart failure and acute heart failure, the hypoxia of the liver resulted from decreased hepatic blood flow (ischemia) due to left-sided heart failure and from venous congestion secondary to right-sided heart failure. In chronic respiratory failure, liver hypoxia was mainly due to profound hypoxemia. In toxic/septic shock, oxygen delivery to the liver was not decreased but oxygen needs were increased, while the liver was unable to use oxygen properly. In all conditions underlying hypoxic hepatitis, except toxic/septic shock, a shock state was observed in only about 50% of the cases. Therefore, the expressions "shock liver" or "ischemic hepatitis" are misleading and should be replaced by the more general term "hypoxic hepatitis."

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14663289     DOI: 10.1097/01.md.0000101573.54295.bd

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  65 in total

Review 1.  Cardiohepatic syndrome.

Authors:  Gerhard Poelzl; Johann Auer
Journal:  Curr Heart Fail Rep       Date:  2015-02

Review 2.  Hepato-cardiac disorders.

Authors:  Yasser Mahrous Fouad; Reem Yehia
Journal:  World J Hepatol       Date:  2014-01-27

Review 3.  Liver - guardian, modifier and target of sepsis.

Authors:  Pavel Strnad; Frank Tacke; Alexander Koch; Christian Trautwein
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-12-07       Impact factor: 46.802

4.  Short and long-term outcomes in patients with acute liver failure due to ischemic hepatitis.

Authors:  Ryan M Taylor; Shannan Tujios; Kartik Jinjuvadia; Timothy Davern; Obaid S Shaikh; Steve Han; Raymond T Chung; William M Lee; Robert J Fontana
Journal:  Dig Dis Sci       Date:  2011-09-27       Impact factor: 3.199

Review 5.  [Statin therapy as a protective factor regarding development of hypoxic hepatitis].

Authors:  A Drolz
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-09       Impact factor: 0.840

6.  Pre-transplant left ventricular diastolic dysfunction is associated with post transplant acute graft rejection and graft failure.

Authors:  Chetan Mittal; Waqas Qureshi; Sumit Singla; Umair Ahmad; Mary Ann Huang
Journal:  Dig Dis Sci       Date:  2013-12-10       Impact factor: 3.199

Review 7.  [Shock liver and cholestatic liver in critically ill patients].

Authors:  A Drolz; T Horvatits; K Roedl; V Fuhrmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-04-27       Impact factor: 0.840

8.  Hypoxic hepatitis and acute liver failure in a patient with newly onset atrial fibrillation and diltiazem infusion.

Authors:  Wu Deng; Laurie Farricielli
Journal:  BMJ Case Rep       Date:  2013-09-16

Review 9.  [Cholestasis and liver dysfunction in critical care patients].

Authors:  M Kredel; J Brederlau; N Roewer; C Wunder
Journal:  Anaesthesist       Date:  2008-12       Impact factor: 1.041

10.  Severe hepatocellular injury after hematopoietic cell transplant: incidence, etiology and outcome.

Authors:  M Sakai; S I Strasser; H M Shulman; S J McDonald; H G Schoch; G B McDonald
Journal:  Bone Marrow Transplant       Date:  2009-03-23       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.